Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

Triathlon Tritanium Cone Augments Outcomes Study

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis

Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis